3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase 2
2
Status
Recruiting
4
Sponsor Class
INDUSTRY
3
OTHER
1
Study Type
Interventional
4
Sponsor
Cancer Type
Breast
4
Conditions
Breast Neoplasms
2
Advanced Breast Cancer
2
Interventions
Letrozole
34
Fulvestrant
31
Specimen Handling
29
ribociclib
22
pembrolizumab
22
Paclitaxel
21
Magnetic Resonance Spectroscopy
20
palbociclib
19
Trastuzumab
19
Anastrozole
19
Carboplatin
18
Capecitabine
18
exemestane
17
abemaciclib
16
Biopsy
16
Tamoxifen
15
pertuzumab
14
trastuzumab deruxtecan
12
Cyclophosphamide
10
Taxes
9
Radiotherapy
8
Goserelin
8
Docetaxel
8
giredestrant
7
Standard of Care
7
130-nm albumin-bound paclitaxel
7
inavolisib
6
eribulin
6
elacestrant
6
atezolizumab
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
4 trials
Recent
Start date
Enrollment
AZD9833
×
Breast
×
30 days
×
Clear all
NCT07195227
2026-05-29
CADILLAC
MedSIR
Phase 2
Recruiting
150 enrolled
NCT05952557
2026-05-28
CAMBRIA-2
AstraZeneca
Phase 3
Recruiting
5,500 enrolled
NCT07427394
2026-05-28
SERENA-1b
AstraZeneca
Phase 2
Recruiting
24 enrolled
NCT06380751
2026-05-15
EvoPAR-BR01
AstraZeneca
Phase 3
Recruiting
500 enrolled